224 related articles for article (PubMed ID: 21405933)
41. Low antibiotic resistance among anaerobic Gram-negative bacteria in periodontitis 5 years following metronidazole therapy.
Dahlen G; Preus HR
Anaerobe; 2017 Feb; 43():94-98. PubMed ID: 27988390
[TBL] [Abstract][Full Text] [Related]
42. High resistance against clindamycin, metronidazole and amoxicillin in Porphyromonas gingivalis and Aggregatibacter actinomycetemcomitans isolates of periodontal disease.
Ardila CM; López MA; Guzmán IC
Med Oral Patol Oral Cir Bucal; 2010 Nov; 15(6):e947-51. PubMed ID: 20383102
[TBL] [Abstract][Full Text] [Related]
43. Bacterial susceptibility to amoxicillin and potassium clavulanate in advanced periodontitis patients not responding to mechanical therapy.
Kleinfelder JW; Müller RF; Lange DE
J Clin Periodontol; 2000 Nov; 27(11):846-53. PubMed ID: 11073328
[TBL] [Abstract][Full Text] [Related]
44. [Errors of the agar diffusion method to predict Escherichia coli's susceptibility to ampicillin-sulbactam and amoxicillin-clavulanic acid].
Villar HE; Jugo MB; Fernández-Lausi A; Farinati AE
Enferm Infecc Microbiol Clin; 1996 May; 14(5):308-10. PubMed ID: 8744371
[TBL] [Abstract][Full Text] [Related]
45. Antibiotic susceptibility of periodontal Streptococcus constellatus and Streptococcus intermedius clinical isolates.
Rams TE; Feik D; Mortensen JE; Degener JE; van Winkelhoff AJ
J Periodontol; 2014 Dec; 85(12):1792-8. PubMed ID: 25102269
[TBL] [Abstract][Full Text] [Related]
46. Surveillance of susceptibility patterns in 1297 European and US anaerobic and capnophilic isolates to co-amoxiclav and five other antimicrobial agents.
Koeth LM; Good CE; Appelbaum PC; Goldstein EJ; Rodloff AC; Claros M; Dubreuil LJ
J Antimicrob Chemother; 2004 Jun; 53(6):1039-44. PubMed ID: 15128729
[TBL] [Abstract][Full Text] [Related]
47. [Pharmacokinetic/pharmacodynamic analysis of antibiotic therapy in dentistry and stomatology].
Isla A; Canut A; Rodríguez-Gascón A; Labora A; Ardanza-Trevijano B; Solinís MA; Pedraz JL
Enferm Infecc Microbiol Clin; 2005 Mar; 23(3):116-21. PubMed ID: 15757581
[TBL] [Abstract][Full Text] [Related]
48. Antibiotic resistance in an in vitro subgingival biofilm model.
Sedlacek MJ; Walker C
Oral Microbiol Immunol; 2007 Oct; 22(5):333-9. PubMed ID: 17803631
[TBL] [Abstract][Full Text] [Related]
49. Subgingival distribution of periodontopathic bacteria in adult periodontitis and their susceptibility to minocycline-HCl.
Hagiwara S; Takamatsu N; Tominaga Y; Umeda M
J Periodontol; 1998 Jan; 69(1):92-9. PubMed ID: 9527568
[TBL] [Abstract][Full Text] [Related]
50. In vitro prevention of the emergence of daptomycin resistance in Staphylococcus aureus and enterococci following combination with amoxicillin/clavulanic acid or ampicillin.
Entenza JM; Giddey M; Vouillamoz J; Moreillon P
Int J Antimicrob Agents; 2010 May; 35(5):451-6. PubMed ID: 20185277
[TBL] [Abstract][Full Text] [Related]
51. Efficacy of antibiotics to strains of periodontopathogenic bacteria within a single species biofilm - an in vitro study.
Eick S; Seltmann T; Pfister W
J Clin Periodontol; 2004 May; 31(5):376-83. PubMed ID: 15086620
[TBL] [Abstract][Full Text] [Related]
52. Microbiological and clinical results of metronidazole plus amoxicillin therapy in Actinobacillus actinomycetemcomitans-associated periodontitis.
van Winkelhoff AJ; Tijhof CJ; de Graaff J
J Periodontol; 1992 Jan; 63(1):52-7. PubMed ID: 1313103
[TBL] [Abstract][Full Text] [Related]
53. Antibiotic Resistance in Patients with Peri-Implantitis: A Systematic Scoping Review.
Ardila CM; Vivares-Builes AM
Int J Environ Res Public Health; 2022 Nov; 19(23):. PubMed ID: 36497685
[TBL] [Abstract][Full Text] [Related]
54. Quorum-quenching enzyme Est816 assisted antibiotics against periodontitis induced by
Wang J; Ju T; Guo L; Shan W; Wu Q; Zhang H; Zhang J
Front Cell Infect Microbiol; 2024; 14():1368684. PubMed ID: 38779565
[TBL] [Abstract][Full Text] [Related]
55. Antimicrobial susceptibility of periodontopathogenic bacteria.
Kulik EM; Lenkeit K; Chenaux S; Meyer J
J Antimicrob Chemother; 2008 May; 61(5):1087-91. PubMed ID: 18326855
[TBL] [Abstract][Full Text] [Related]
56. [In vitro sensitivity of Actinobacillus actinomycetemcomitans to various antibiotics].
Akincibay H; Kocagöz T; Alaçam R
Mikrobiyol Bul; 1993 Apr; 27(2):147-53. PubMed ID: 8502187
[TBL] [Abstract][Full Text] [Related]
57. European surveillance study on antimicrobial susceptibility of Gram-positive anaerobic cocci.
Brazier J; Chmelar D; Dubreuil L; Feierl G; Hedberg M; Kalenic S; Könönen E; Lundgren B; Malamou-Ladas H; Nagy E; Sullivan A; Nord CE;
Int J Antimicrob Agents; 2008 Apr; 31(4):316-20. PubMed ID: 18180149
[TBL] [Abstract][Full Text] [Related]
58. In vitro activities of DX-619 and four comparator agents against 376 anaerobic bacterial isolates.
Molitoris D; Väisänen ML; Bolaños M; Finegold SM
Antimicrob Agents Chemother; 2006 May; 50(5):1887-9. PubMed ID: 16641470
[TBL] [Abstract][Full Text] [Related]
59. Change of antibiotic susceptibility following periodontal therapy. A pilot study in aggressive periodontal disease.
Buchmann R; Müller RF; Van Dyke TE; Lange DE
J Clin Periodontol; 2003 Mar; 30(3):222-9. PubMed ID: 12631180
[TBL] [Abstract][Full Text] [Related]
60. Facial cellulitis because of Aggregatibacter (Actinobacillus) actinomycetemcomitans and Capnocytophaga species in an immunocompetent patient.
Hsieh CJ; Hwang KP; Kuo KC; Hsueh PR
J Microbiol Immunol Infect; 2011 Apr; 44(2):149-51. PubMed ID: 21439519
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
